| Literature DB >> 27841902 |
Marius J Swart1, Gina Joubert2, Jan-Albert van den Berg3, Gert J van Zyl4.
Abstract
AIM: The purpose of this article is to present the results of a private cardiac surgical practice. This information could also serve as a hermeneutical text for new wisdom.Entities:
Mesh:
Year: 2016 PMID: 27841902 PMCID: PMC5125284 DOI: 10.5830/CVJA-2015-081
Source DB: PubMed Journal: Cardiovasc J Afr ISSN: 1015-9657 Impact factor: 1.167
Additional procedures to the CABG
| Aorta dissection (intra-operative complication) | 1 | 0.1 |
| Aortic valve replacement | 51 | 2.9 |
| Aortic valve + mitral valve replacement | 3 | 0.2 |
| Aortic valve + mitral valve replacement + Maze | 1 | 0.1 |
| ASD | 1 | 0.1 |
| ASD + Maze | 1 | 0.1 |
| Biopsies for carcinoma | 3 | 0.2 |
| Left ventricular aneurysm | 2 | 0.1 |
| Left ventricular aneurysm + Maze | 1 | 0.1 |
| Left ventricular rupture | 1 | 0.1 |
| Maze | 6 | 0.3 |
| Mitral valve repair | 15 | 0.9 |
| Mitral valve repair + Maze | 2 | 0.1 |
| Mitral valve replacement | 29 | 1.7 |
| Mitral valve replacement + Maze | 4 | 0.2 |
| VSD (ischaemic) | 1 | 0.1 |
ASD, atrio-septal defect; VSD, ventriculo-septal defect.
Profile of CABG patients
| Females | 406 | 23.2 |
| Males | 1344 | 78.8 |
| ≤ 39 years | 39 | 2.2 |
| 40–49 years | 204 | 11.7 |
| 50–59 years | 505 | 28.9 |
| 60–69 years | 604 | 34.5 |
| 70–79 years | 363 | 20.7 |
| ≥ 80 years | 35 | 2.0 |
| Diabetes mellitus | 442 | 25.3 |
| Urgent (IABP/ventilator) | 312 | 17.8 |
| Renal impairment (CKD III) | 376 | 21.7 |
| Re-operation (2nd, 3rd, 4th operation) | 196 | 11.2 |
| Additional procedure | 122 | 7.0 |
CKD, chronic kidney disease; IABP, intra-aortic balloon pump.
Reason for death
| Cardiac (death in theatre) | 5 (9.4) |
| Surgical bleed | 1 (1.9) |
| Sudden and unexplainable | 5 (9.4) |
| Stroke | 2 (3.8) |
| Brain dead | 1 (1.9) |
| Inflammatory conditions (DIC, IE, sepsis, SIRS) | 7 (13.2) |
| Gastrointestinal | 3 (5.7) |
| Organ failure (cardiac, respiratory, renal, MOF) | 28 (52.8) |
| Pining away | 1 (1.9) |
DIC, diffuse intravascular coagulopathy; IE, infective endocarditis; MOF, multiorgan failure; SIRS, systemic inflammatory response syndrome.
Core risk factors25
| < 70 years | 31/1 352 | 2.3 | |
| ≥ 70 years | 22/398 | 5.5 | 0.0009 |
| Male | 46/1 344 | 3.4 | |
| Female | 7/406 | 1.7 | 0.0801 |
| 1st sternotomy | 35/1 554 | 2.3 | |
| 2nd sternotomy | 14/179 | 7.8 | |
| 3rd sternotomy | 4/15 | 26.7 | |
| 4th sternotomy | 0/2 | 0.0 | < 0.0001 |
| No left main stem | 34/1 420 | 2.4 | |
| Left main stem | 19/330 | 5.8 | 0.0013 |
| LVEF ≥ 40% | 41/1 652 | 2.5 | |
| LVEF < 40% | 12/98 | 12.2 | < 0.0001 |
| Home/ward | 14/570 | 2.5 | |
| CCU | 21/868 | 2.4 | |
| IABP | 12/299 | 4.0 | |
| Ventilator/lab | 6/13 | 46.2 | < 0.0001 |
CCU, coronary care unit; IABP, intra-aortic balloon pump; lab, catheter laboratory; LVEF, left ventricular ejection fraction.
Cardiologist’s mortality/risk and contribution to the cohort
| A | 12/484 | 2.5 | 3.57 | 27.6 |
| B | 19/335 | 5.7 | 4.76 | 19.1 |
| C | 0/58 | 0.0 | 4.36 | 3.1 |
| D | 5/309 | 1.6 | 3.69 | 17.7 |
| E | 11/431 | 2.6 | 3.55 | 24.6 |
| F | 6/133 | 4.5 | 4.17 | 7.6 |
Significant risk factors in logistic regression with odds ratio
| Urgency (IABP) | 2.21 | 1.13–4.32 |
| Renal impairment (CKD III) | 2.58 | 1.44–4.65 |
| Re-operation | 4.31 | 2.32–8.00 |
| Additional procedure | 7.14 | 3.60–14.18 |
CI, confidence interval; CKD, chronic kidney disease; OR, odds ratio; IABP, intra-aortic balloon pump.
Major morbidities
| Re-exploration | 32 (1.8)* |
| Prolonged ventilation | 36 (2.1) |
| Renal failure | 32 (1.8) |
| Permanent stroke | 20 (1.1) |
| Sternal dehiscence | 17 (1.0) |
The percentage was calculated from 1 745 patients as five died in theatre.
*31 for bleeding and one instrument that was left behind.
28 patients had more than one major complication (Table 8).
Patients with associated major complications
| 94 | Single | 17 (18.1) |
| 23 | Double | 12 (52.2) |
| 5 | Triple | 2 (40.0) |
| 1 623* | None | 17 (1.0) |
*Five patients died in theatre and had no major complications.
The number of patients was 1 750 (5 + 94 + 23 + 5 + 1 623).
The number of deaths was 53 (5 + 17 + 12 + 2 + 17).
Outcome associated with mediastinal drainage
| ≥ 1 070 ml | 180 (10.3) | 17 (9.4) | 29 (16.1) |
| < 1 070 ml | 1 565 (89.7) | 31 (2.0) | 3 (0.2)** |
*Five patients died in theatre (total mortality 53).
**The re-explorations were in two patients who drained 950 and 975 ml and the third patient had to be re-opened to remove a surgical instrument.
Risk, mortality and blood bank usage
| No bank blood (n = 1 346) | 3.43 | 23 (1.7) |
| Bank blood (n = 404) | 5.33 | 30 (7.4) |
| Only 1–2 units RBC (n = 222) | 4.95 | 6 (2.7) |
| ≥ 3 units RBC (n = 123) | 6.05 | 20 (16.3) |
RBC, red blood cells. *Bank blood includes red blood cells, plasma and/or platelets.
Length of stay and age
| Age (years) | 5 |
| ≤ 39 (n = 39) | 4 |
| 40–49 (n = 203) | 4 |
| 50–59 (n = 495) | 5 |
| 60–69 (n = 584) | 5 |
| 70–79 (n = 346) | 6 |
| ≥ 80 (n = 30) | 9 |
Length of stay and EuroSCORE
| EuroSCORE | 5 |
| ≤ 2 (n = 630) | 5 |
| 3–5 (n = 644) | 5 |
| 6–9 (n = 365) | 6 |
| ≥ 10 (n = 58) | 10 |
Comparison of isolated CABG mortality with other databases
| Tabula viva chirurgi | 2000–2012 | 1 628 | 2.21 |
| EuroSCORE23 | 1998 | 12 103 | 3.40 |
| STS22 | 2000–2006 | 774 881 | 2.30 |
| JACVSD35 | 2000–2005 | 7 133 | 2.72 |
JACVSD, Japan Adult Cardiovascular Surgery Database; STS, Society of Thoracic Surgeons.